DBV Technologies S.A. (DBVT) Insider Trading

Over the last 6 months, 26 institutions increased and 19 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
Insider trades by month Buys Sells
Jan
May
Jul
Nov
Dec
Feb
Context3-month price -28.2%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Feb 2, 2026Mohideen Pharisofficer: Chief Medical OfficerSell534$4.86
Jan 14, 2026BAKER BROS. ADVISORS LPdirectorOption25,005,240—
Jan 14, 2026BAKER BROS. ADVISORS LPdirectorOption2,299,656—
Dec 19, 2025EPIC Bpifranceother: Member of 10% owner groupSell1,292,103$4.19
Dec 19, 2025EPIC Bpifranceother: Member of 10% owner groupSell2,036,990$4.84
Dec 19, 2025EPIC Bpifranceother: Member of 10% owner groupSell40,000$5.28
Nov 25, 2025Mohideen Pharisofficer: Chief Medical OfficerGrant44,000—
Nov 25, 2025Mohideen Pharisofficer: Chief Medical OfficerGrant253,000$2.90
Nov 25, 2025Mohideen Pharisofficer: Chief Medical OfficerSell6,496$2.88
Nov 25, 2025Mohideen Pharisofficer: Chief Medical OfficerSell1,624$2.77
Nov 24, 2025Boucinha Virginieofficer: Chief Financial OfficerGrant192,000$2.90
Nov 24, 2025Boucinha Virginieofficer: Chief Financial OfficerGrant32,000—
Nov 24, 2025Trapp Kevin Michaelofficer: Chief Commercial OfficerGrant316,250$2.90
Nov 24, 2025Trapp Kevin Michaelofficer: Chief Commercial OfficerGrant55,000—
Nov 24, 2025Tasse Danieldirector, officer: CHIEF EXECUTIVE OFFICERGrant964,000$2.90
Jul 31, 2025Mohideen Pharisofficer: Chief Medical OfficerSell464$2.22
May 27, 2025Mohideen Pharisofficer: Chief Medical OfficerSell397$1.84
Mar 31, 2025BAKER BROS. ADVISORS LPdirector, 10 percent owner: Grant25,005,240—
Mar 31, 2025BAKER BROS. ADVISORS LPdirector, 10 percent owner: Grant2,299,656—
Jan 31, 2025Mohideen Pharisofficer: Chief Medical OfficerSell600$0.85
Dec 5, 2024Tasse Danieldirector, officer: CHIEF EXECUTIVE OFFICERGrant813,200$0.89
Nov 27, 2024Mohideen Pharisofficer: Chief Medical OfficerSell342$0.53
Nov 27, 2024Mohideen Pharisofficer: Chief Medical OfficerSell565$0.57
Nov 25, 2024Mohideen Pharisofficer: Chief Medical OfficerGrant215,000$0.75
Nov 25, 2024Mohideen Pharisofficer: Chief Medical OfficerGrant35,000—
Nov 25, 2024Mohideen Pharisofficer: Chief Medical OfficerSell2,350$0.54
Nov 25, 2024Boucinha Virginieofficer: Chief Financial OfficerGrant113,000$0.75
Nov 25, 2024Boucinha Virginieofficer: Chief Financial OfficerGrant19,000—
Jul 31, 2024Mohideen Pharisofficer: Chief Medical OfficerSell1,785$0.98
May 29, 2024Mohideen Pharisofficer: Chief Medical OfficerSell382$1.38

Source: DBVT SEC Form 4 filings, latest Feb 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their DBVT positions over the last 6 months (SEC Form 13F).

Increased
26
New positions
56
Reduced
19
Sold out
25
Largest moves
InstitutionActionSharesFiled
BIOIMPACT CAPITAL LLCIncreased5.2MMay 15, 2026
ARTISAN PARTNERS LIMITED PARTNERSHIPIncreased3.3MFeb 17, 2026
VIVO CAPITAL, LLCIncreased2.7MMay 20, 2026
VIVO CAPITAL, LLCIncreased2.5MFeb 13, 2026
ARTISAN PARTNERS LIMITED PARTNERSHIPReduced2.2MMay 13, 2026
SIREN, L.L.C.New Position1.9MFeb 13, 2026
SIREN, L.L.C.Unchanged1.9MMay 14, 2026
BAKER BROS. ADVISORS LPUnchanged1.5MMay 15, 2026
BAKER BROS. ADVISORS LPUnchanged1.5MFeb 17, 2026
ADAR1 CAPITAL MANAGEMENT, LLCNew Position1.0MMay 18, 2026
BIOIMPACT CAPITAL LLCReduced997KFeb 17, 2026
PERCEPTIVE ADVISORS LLCNew Position964KMay 29, 2026
PATIENT SQUARE CAPITAL LPIncreased694KMay 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased641KFeb 17, 2026
YIHENG CAPITAL MANAGEMENT, L.P.Reduced640KFeb 17, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to DBVT overview (price, financials, earnings)